SEC Filing Summary for BioLineRx Ltd. (BLRX)

This filing details the ownership of BioLineRx Ltd. (BLRX) by Mali Zeevi, the Chief Financial Officer. The report includes information on stock options granted under the 2003 Amended and Restated Share Incentive Plan, with various grant and vesting dates. Specifically, it lists 8 separate option grants with exercise dates ranging from October 9, 2016, to November 19, 2025, and corresponding expiration dates. The number of underlying ordinary shares for these options varies, with exercise prices also differing. Footnotes provide details on the nature of these options, including vesting schedules and tax-related trustee arrangements. In addition to stock options, the filing also reports direct ownership of 1,311,000 ordinary shares of BioLineRx Ltd.